semaglutide standard generics likely to widen access but raise dropout risks | Industry News Medical Weight Loss Treatments |
Description
How can people access Wegovy

The review included eight studies administered semaglutide by subcutaneous injection in doses ranging from 0.5 to 2.4 mg, nine studies administered semaglutide by oral route in doses ranging from 2 to 40 mg

Employees can sometimes request the employer/benefits administrator review the exclusion or consider an exception process

There was a sick little part of myself that was pleased, even though I felt miserable and was subsisting on chicken soup and saltine crackers

Liraglutide is also not a match for every patient

Celine Gounder breaks down the findings
